Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NVAX
#2199
Novavax, Inc. - Common Stock
9.1
4
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.74%
Monthly Change
+25.38%
6 month change
-6.54%
Year Change
+20.90%
Previous Close
9.0
5
Open
9.1
8
Low
9.0
0
High
9.2
7
Volume
530
Markets
US Stock Market
Healthcare
Biotechnology
NVAX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
73.86 M
76.28 M
86.17 M
139.95 M
160.84 M
162.94 M
164.95 M
Valuation ratios
Enterprise value
8.11 B
9.85 B
25.3 M
308.62 M
939.65 M
1.1 B
1.31 B
Price to earnings ratio
—
-6.1
-1.16
-0.93
-6.54
2.6
-6.76
Price to sales ratio
—
9.29
0.39
0.52
1.79
1.04
3.67
Price to cash flow ratio
—
32.96
-1.84
0.71
14.02
-4.76
-44.5
Price to book ratio
—
-30.27
-1.21
0.71
1.96
-9.11
-2.43
Enterprise value to EBITDA ratio
-19.67
-5.89
-0.04
-0.59
-4.68
2.29
—
Profitability ratios
Return on assets %
-0.26
-0.68
-0.29
-0.3
-0.12
0.37
-0.06
Return on equity %
-0.67
4.96
1.04
0.76
0.3
-3.45
0.28
Return on invested capital %
-590.32
-485.21
-121.46
-113.76
-60.39
342.59
-54.91
Gross margin %
100
100
54.46
65.05
70.28
93.5
74.87
Operating margin %
-87.62
-147.13
-32.53
-57.59
-36.49
40.3
-96.84
EBITDA margin %
-86.72
-146.04
-31.06
-53.42
-29.46
42.8
—
Net margin %
-87.94
-152.12
-33.2
-55.41
-27.49
39.19
-94.16
Liquidity ratios
Quick ratio
—
—
0.68
0.67
0.97
2.1
2.3
Current ratio
2.15
0.9
0.69
0.7
0.98
2.13
2.33
Inventory turnover
—
—
2.09
-0.03
1.13
0.19
0.15
Asset turnover
0.54
0.55
0.82
0.49
0.41
0.95
0.06
Solvency ratios
Debt to assets ratio
0.27
0.18
0.23
0.1
0.11
0.21
—
Debt to equity ratio
0.68
-1.29
-0.82
-0.24
-0.28
-1.93
—
Long term debt to total assets ratio
0.2
0.13
-0
-0
-0
-0.01
0.31
Long term debt to total equity ratio
0.51
-0.92
0.01
0.01
0.01
0.06
-1.53
Per share metrics
Operating cash flow per share
—
4.34
-5.32
-7.09
-0.57
-1.41
-0.21
EBIT per share
—
-22.67
-8.25
-5.62
-1.64
2.62
-1.44
EBITDA per share
—
-22.5
-7.87
-5.22
-1.32
2.78
—
Total debt per share
—
6.1
6.63
1.72
1.16
1.43
—
Cash per share
—
20.36
17.1
5.64
6.07
4.25
4.37
Net current asset value per share
—
28.97
21.79
11.35
7.42
5.65
4.69
Tangible book value per share
—
-4.73
-8.11
-7.11
-4.1
-1.39
-1.84
Working capital per share
—
-3.16
-9.68
-4.88
-0.17
2.99
2.68
Book value per share
—
-4.73
-8.11
-7.11
-4.1
-0.74
-1.16
News
Novavax Stock Rallies Tuesday: What's Happening? - Novavax (NASDAQ:NVAX)
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough
Novavax Stock Moves Higher Wednesday: What's Driving the Action? - Novavax (NASDAQ:NVAX)
Moderna shares double as cancer vaccine data rekindles investor hopes
NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised
ADMA Q2 Earnings Meet, Revenues Miss on Bivigam Weakness
Novavax (NVAX) Reports Q2 Loss, Tops Revenue Estimates
Are Medical Stocks Lagging Novavax (NVAX) This Year?
HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up
Novavax: The Beaten-Down COVID-19 Darling (NASDAQ:NVAX)
Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know